A team of researchers has found disrupting the interaction between cancer cells and certain immune cells is more effective at…

Home »
A team of researchers has found disrupting the interaction between cancer cells and certain immune cells is more effective at…
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg~Kimmel Institute for Cancer…
The checkpoint inhibitor nivolumab is efficacious and well tolerated when used as adjuvant therapy in patients who have undergone radical…
A paper published today in Nature shows how chemicals in the areas surrounding tumors—known as the tumor microenvironment—subvert the immune…
For all their importance as a breakthrough treatment, the cancer immunotherapies known as checkpoint inhibitors still only benefit a small…
TARRYTOWN, N.Y. and PARIS, Feb. 9, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.…
Activating an immune signaling pathway best known for fighting viral and bacterial infections can boost the ability of genetically engineered…
A new study from the University of Birmingham has found that 50% of patients with a rare type of cancer…
Scientists at UCL have discovered new biomarkers, which may identify those people with Type 1 diabetes who would benefit from…
Immunotherapy is a powerful weapon in the fight against cancer, but inflammation of the heart muscle (myocarditis) is one of…